Headlines in the Global Wellness Economy

Global Wellness News™ | June 30th, 2026

Unilever exploring $4 billion bid for Thorne supplements

L Catterton, the LVMH-backed private equity firm that took Thorne private for $680 million in 2023, is seeking a valuation of up to $4 billion

A New $500 Million Fund Is Trying to Eliminate the Common Cold

The project, called Intercept, aims to financially back the development of treatments that protect against respiratory infections of all kinds, plus technology to clean air.

Silicon Valley’s longevity drug obsession is facing its first real reality check

Bryan Johnson, the tech entrepreneur who turned his body into a public experiment, stopped taking Rapamycin in September 2024 after several years of self-testing the drug. The…

Nike’s ‘mind-altering’ shoes are flying off shelves. Is this the era of ‘passive neuro-wearables’? | CNN

Nike’s Mind shoe range has rapidly sold out across worldwide releases with buyers eager to get their hands on the “neuroscience-based footwear.”

Peers Capital bets on prevention before the pivot

New deal-by-deal syndicate is backing founders in diagnostics, longevity, recovery and behavior change – before traditional investors arrive.

Xella Health Launches Multi-Omic Diagnostics Platform for Women’s Care

Aiming to “replace systemic medical gaslighting,” co-founder Kelly Lacob wants to make indisputable biological data the standard for care.

Curated Global Wellness News is posted every Tuesday and Thursday on the Industry News section of the GWS website. Sign up to receive weekly industry news, trends and updates from the Global Wellness Summit.